Corcept Therapeutics (CORT) came out with quarterly earnings of $0.29 per share, beating the Zacks Consensus Estimate of $0.23 per share. This compares to earnings of $0.32 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +26.09%. A quarter ago, it was expected that this drug developer would post earnings of $0.17 per share when it actually produced earnings of $0.17, delivering no surprise.Over the last four quarters, the comp ...

Exponent (EXPO) came out with quarterly earnings of $0.52 per share, beating the Zacks Consensus Estimate of $0.48 per share. This compares to earnings of $0.57 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +8.33%. A quarter ago, it was expected that this engineering and scientific consulting company would post earnings of $0.48 per share when it actually produced earnings of $0.52, delivering a surprise of +8.33%.Over the l ...

Zynex Inc. (ZYXI) came out with a quarterly loss of $0.32 per share versus the Zacks Consensus Estimate of a loss of $0.2. This compares to earnings of $0.04 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -60.00%. A quarter ago, it was expected that this company would post a loss of $0.2 per share when it actually produced a loss of $0.33, delivering a surprise of -65%.Over the last four quarters, the company has surpassed co ...

公司业绩表现 - Baxter International最新季度每股收益为0 59美元 低于Zacks共识预期的0 6美元 同比去年同期的0 68美元下降[1] - 季度营收28 1亿美元 低于共识预期0 28% 同比去年同期的38 1亿美元下降[2] - 过去四个季度中 公司三次超过每股收益预期 两次超过营收预期[2] 市场反应与股价表现 - 本季度业绩公布后 公司股价年初至今下跌3 8% 同期标普500指数上涨8 2%[3] - 公司当前Zacks评级为3(持有) 预计短期内表现将与市场持平[6] 未来展望 - 下季度共识预期每股收益0 64美元 营收29亿美元 本财年预期每股收益2 5美元 营收113 5亿美元[7] - 业绩电话会议中管理层的评论将影响股价短期走势[3] 行业比较 - 所属医疗产品行业在Zacks行业排名中处于后26%位置[8] - 同行业公司Curaleaf Holdings预计下季度每股亏损0 07美元 同比恶化16 7% 营收预计3 1535亿美元 同比下降7 9%[9][10]

InterDigital (IDCC) came out with quarterly earnings of $6.52 per share, beating the Zacks Consensus Estimate of $3.36 per share. This compares to earnings of $4.57 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +94.05%. A quarter ago, it was expected that this wireless research and development company would post earnings of $3.72 per share when it actually produced earnings of $4.21, delivering a surprise of +13.17%.Over the ...

季度业绩表现 - 公司季度每股收益为1.88美元，超出Zacks共识预期的1.83美元，同比增长2.73% [1] - 季度营收达1.8688亿美元，超出共识预期4%，同比增长9% [2] - 过去四个季度均超出每股收益和营收预期 [2] 历史业绩与市场表现 - 上一季度实际每股收益2.22美元，超出预期15.03% [1] - 公司股价年内下跌7.5%，同期标普500指数上涨8.2% [3] 未来展望 - 当前季度共识预期每股收益1.84美元，营收1.7755亿美元 [7] - 当前财年共识预期每股收益8美元，营收7.2324亿美元 [7] - 公司当前Zacks评级为3级(持有)，预计将与市场表现一致 [6] 行业情况 - 咨询服务业在Zacks行业排名中位列前20% [8] - 同行业公司Stantec预计季度每股收益0.98美元，同比增长19.5% [9] - Stantec预计季度营收11.8亿美元，同比增长8.4% [9]

MasterCard (MA) came out with quarterly earnings of $4.15 per share, beating the Zacks Consensus Estimate of $4.05 per share. This compares to earnings of $3.59 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +2.47%. A quarter ago, it was expected that this processor of debit and credit card payments would post earnings of $3.57 per share when it actually produced earnings of $3.73, delivering a surprise of +4.48%.Over the las ...

Bristol Myers Squibb (BMY) came out with quarterly earnings of $1.46 per share, beating the Zacks Consensus Estimate of $1.07 per share. This compares to earnings of $2.07 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +36.45%. A quarter ago, it was expected that this biopharmaceutical company would post earnings of $1.51 per share when it actually produced earnings of $1.8, delivering a surprise of +19.21%.Over the last four ...

Teleflex (TFX) came out with quarterly earnings of $3.73 per share, beating the Zacks Consensus Estimate of $3.36 per share. This compares to earnings of $3.42 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +11.01%. A quarter ago, it was expected that this medical equipment maker would post earnings of $2.88 per share when it actually produced earnings of $2.91, delivering a surprise of +1.04%.Over the last four quarters, the ...

Omnicell (OMCL) came out with quarterly earnings of $0.45 per share, beating the Zacks Consensus Estimate of $0.31 per share. This compares to earnings of $0.51 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +45.16%. A quarter ago, it was expected that this Omnicell Inc. would post earnings of $0.16 per share when it actually produced earnings of $0.26, delivering a surprise of +62.5%.Over the last four quarters, the company ...